Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Using the national electronic prescription system to determine the primary non-adherence to medication in the Czech Republic

J. Bruthans, J. Berger, J. Šoltés, P. Michálek

. 2023 ; 14 (-) : 1128457. [pub] 20230322

Status not-indexed Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc23010132

The primary medication non-adherence occurs when a patient does not collect his or her newly prescribed medication. Various studies give estimates that this occurs between 0.2 percent and 74 percent. Recently, this topic has been researched by analyzing data in national electronic prescription systems. The database of the Czech electronic prescription system was used to obtain the number of all prescriptions issued and collected in 2021 for fifty particular substances (associated with six medication groups). Additionally, a similar query was performed with an additional criterion that the same substance had not been prescribed within the last 365 days. The data were obtained separately in five age categories. The total number of prescriptions analyzed in this study was over 21 million, which represents almost 30 percent of all prescriptions issued in the Czech Republic in 2021. The primary medication non-adherence in the selected substances was 4.56 percent, which negatively correlates (rxy = 0.707) with the age of a patient. There is a higher primary non-adherence in the Psychoanaleptics and Lipid modifying medication groups than in the whole studied sample (p < 0.05). Lipid-modifying medication group and several other particular substances showed a larger difference between primary non-adherence and overall non-adherence, indicating issues in the initiation of these drugs. The results of our study are following earlier studies with similar methodologies from other countries. However, the difference between primary non-adherence and overall non-adherence had not been observed in other studies before. The electronic prescription system proved to be a valuable tool for conducting this type of research.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010132
003      
CZ-PrNML
005      
20230721095319.0
007      
ta
008      
230707s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fphar.2023.1128457 $2 doi
035    __
$a (PubMed)37033608
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bruthans, Jan $u Department of Anesthesiology and Intensive Care, General Teaching Hospital, Prague, Czechia $u Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University, Prague, Czechia
245    10
$a Using the national electronic prescription system to determine the primary non-adherence to medication in the Czech Republic / $c J. Bruthans, J. Berger, J. Šoltés, P. Michálek
520    9_
$a The primary medication non-adherence occurs when a patient does not collect his or her newly prescribed medication. Various studies give estimates that this occurs between 0.2 percent and 74 percent. Recently, this topic has been researched by analyzing data in national electronic prescription systems. The database of the Czech electronic prescription system was used to obtain the number of all prescriptions issued and collected in 2021 for fifty particular substances (associated with six medication groups). Additionally, a similar query was performed with an additional criterion that the same substance had not been prescribed within the last 365 days. The data were obtained separately in five age categories. The total number of prescriptions analyzed in this study was over 21 million, which represents almost 30 percent of all prescriptions issued in the Czech Republic in 2021. The primary medication non-adherence in the selected substances was 4.56 percent, which negatively correlates (rxy = 0.707) with the age of a patient. There is a higher primary non-adherence in the Psychoanaleptics and Lipid modifying medication groups than in the whole studied sample (p < 0.05). Lipid-modifying medication group and several other particular substances showed a larger difference between primary non-adherence and overall non-adherence, indicating issues in the initiation of these drugs. The results of our study are following earlier studies with similar methodologies from other countries. However, the difference between primary non-adherence and overall non-adherence had not been observed in other studies before. The electronic prescription system proved to be a valuable tool for conducting this type of research.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Berger, Jiří $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czechia
700    1_
$a Šoltés, Ján $u Department of Anesthesiology and Intensive Care, General Teaching Hospital, Prague, Czechia
700    1_
$a Michálek, Pavel $u Department of Anesthesiology and Intensive Care, General Teaching Hospital, Prague, Czechia $u Department of Anaesthesia, Antrim Area Hospital, Antrim, United Kingdom
773    0_
$w MED00174597 $t Frontiers in pharmacology $x 1663-9812 $g Roč. 14, č. - (2023), s. 1128457
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37033608 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095312 $b ABA008
999    __
$a ok $b bmc $g 1958647 $s 1196396
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 14 $c - $d 1128457 $e 20230322 $i 1663-9812 $m Frontiers in pharmacology $n Front Pharmacol $x MED00174597
LZP    __
$a Pubmed-20230707

Find record

Citation metrics

Archiving options